DexCom's body sensor paired with Apple Watch app will track and display glucose levels
Context & Ripple Effects
This 2015 report is the earliest data point in a decade-long glucose arc the coverage traces end to end: DexCom's body sensor displaying readings through an [[a:?|Apple Watch]] app was the wrist-first template before any built-in sensor existed. Two years later Tim Cook was reportedly test-driving a prototype glucose-tracker at the Apple campus (Cook's prototype session), while The Verge laid out why non-invasive measurement remained scientifically hard (the technical challenges).
What changed since: Apple kept pushing into blood-sugar features, including an internal app tested to help people with prediabetes manage food intake and lifestyle (Apple's prediabetes app), and by 2026 Google answered on the same turf with an AI-driven insulin-resistance trend feature launching on the Pixel Watch 5 and Fitbit. The DexCom pairing matters because it shows the workaround that shipped first — a certified external sensor feeding the watch — while the watchmakers chase native measurement.
First-order effects
- DexCom users get glucose readings on their wrist via the paired Apple Watch app, removing the phone or dedicated reader from the daily loop for diabetes management.
- Apple gains a marquee health use case for the Watch that no software-only competitor could match, anchoring the device beyond fitness.
Second-order effects
- Google's eventual move — an insulin-resistance trend feature on Pixel Watch 5 and Fitbit devices using AI plus accelerometer data — is the direct competitive response to Apple's glucose positioning, turning metabolic health into a platform differentiator.
- CGM makers like DexCom become strategic partners rather than accessory vendors: whichever watch ecosystem they integrate with inherits their clinical credibility and installed base.
Third-order effects
- If native glucose sensing matures, smartwatch platforms shift from wellness tracking to chronic-disease management — territory where regulators, not app stores, set the bar; notably, the Apple Watch already sees clinician use for diagnostic purposes despite lacking specific FDA approval for those applications, which foreshadows the regulatory friction ahead.
- Metabolic health becomes the next battleground after heart rate and SpO2, with each platform racing to own the data layer patients and doctors rely on.
The trend: Wearables are converging on glucose and metabolic health as the defining feature race, with sensor partnerships like DexCom's paving the way toward fully integrated, regulator-scrutinized medical monitoring on the wrist.